Search
AngioDynamics Inc
ANGOAdd to Watchlist
12.120USD
+0.390+3.32%
Close 11-09 16:00（ET）
509.65MMarket Cap
LossP/E TTM
AngioDynamics Inc (ANGO) Stock Price Target & Forecast
Analyst Rating
Based on 4 analysts giving stock ratings to AngioDynamics Inc in the past month.
Buy
0 Strong Buy
4 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
19.750USD+64.72%
ANGO Analyst Recommendation Trends
In the current month, ANGO has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ANGO average Analyst price target in the last month is 19.750.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
0
0
1
1
1
4
4
4
4
4
4
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
4
4
4
5
4
4
ANGO Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Stryker Corp
SYK
10
14
6
0
0
30
Medtronic PLC
MDT
8
11
10
0
0
29
Dexcom Inc
DXCM
13
12
4
0
0
29
Guardant Health Inc
GH
12
14
2
0
0
28
Abbott Laboratories
ABT
11
13
4
0
0
28
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Zimmer Biomet Holdings Inc
ZBH
2
5
20
0
0
27
Insulet Corp
PODD
7
7
12
0
0
26
Tandem Diabetes Care Inc
TNDM
5
8
10
0
0
23
Repligen Corp
RGEN
5
12
4
0
0
21
Financial Forecasting
Based on analysts' estimates, ANGO EPS is projected to reach -0.065 in FY2027Q2, following reported EPS of -0.169 in FY2027Q1. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q3
FY2026Q4
FY2027Q1
FY2027Q2
FY2027Q3
Forecast
-0.11
-0.09
-0.11
-0.07
-0.10
Actual
-0.19
-0.27
-0.17
--
--
Surprise
-76.68%
-203.87%
-49.02%
--
--
FAQs
What is AngioDynamics Inc's expected revenue for the next quarter?
AngioDynamics Inc's expected revenue is 84.20M.
What is AngioDynamics Inc's price target?
Analysts forecast that AngioDynamics Inc's price target is USD 19.75, with the highest forecast at USD 24.00 and the lowest forecast at USD 17.00.
How have AngioDynamics IncANGO's recent earnings per share performed?
The market expectation was USD -0.17, while AngioDynamics IncANGO's earnings per share (EPS) for the previous quarter was USD -0.27. EPS for the next quarter is expected at USD -0.07.
What is the analyst rating for AngioDynamics Inc?
Based on the ratings of AngioDynamics Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.